Back to search
FDAFDA · Food and drugs·Recall number Z-0134-2022

SIGNA Pioneer nuclear magnetic resonance imaging system

Published October 27, 2021 · Recall initiated: August 26, 2021

Summary

FDA records medical device Class II recall Z-0134-2022, published October 27, 2021 and initiated August 26, 2021. Recalling firm: GE Healthcare, LLC; Status: Terminated; Reported quantity: 5 devices; Lot: Software version PX29.1; and PX25.4 (T), PX28.3 (China only). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Under certain conditions, some slices may be missing which can lead to a gap of anatomy in the 3D Volume images.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GE Healthcare, LLC
Distributor
Distribution in United States to AZ, CA, FL, GA, IL, LA, MA, MD, MN, NC, NH, NJ, NY, OH, OK, TX, VA, WA, and Puerto Rico OUS distribution to: Australia, Belgium, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Poland, Saudi Arabia, Spain, Sweden, Turkey, UAE, and UK
Lot
Software version PX29.1; and PX25.4 (T), PX28.3 (China only)
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was SIGNA Pioneer nuclear magnetic resonance imaging system recalled?

Yes. FDA published recall Z-0134-2022 on October 27, 2021. Reported hazard: Under certain conditions, some slices may be missing which can lead to a gap of anatomy in the 3D Volume images.

What should I do if I have this product?

Voluntary: Firm initiated · Letter